New Smart Device Provides Geolocation and Behavior Tracking Capabilities for Dogs
MADISON, NJ, October 18, 2022 /PRNewswire/ — Merck Animal Health, known as MSD Animal Health outside of the United States Y Canadaa division of Merck & Co, Inc., Rahway, NJUSA (NYSE:MRK), today announced the US launch of Animo® GPS, an activity and behavior monitor for dogs with GPS tracking capabilities. The product can alert pet owners within 20 seconds if their dog leaves its designated “Safe Zone” and offers real-time tracking with location updates every five seconds when in “Lost Dog Mode”.
“One in three dogs will go missing in their lifetime and 80 percent of them will escape from their own home or yard.1. Speaking from experience, it only takes a moment for a dog to run away, and knowing within seconds that he has done so can make all the difference in ensuring a safe return home,” he said. cristina real, DVM, associate vice president of Companion Animals and Equines, Merck Animal Health. “Speed and accuracy were critical product features when we developed Animo GPS, so owners can be quickly alerted when their dog runs away.”
In addition to its location tracking capabilities, Animo GPS uses smart technology to track a dog’s unique activity levels and behavior within an easy-to-use mobile app. The device captures data on sleep quality, barking, scratching, and shaking. It uses an adaptive algorithm to interpret this information and can send an alert through the app if there are significant changes in these behaviors. This data is important because tracking behaviors and trends over time can indicate potential health issues and could provide topics for pet owners to discuss with a veterinary professional.
Animo GPS has a best-in-class battery life of up to 12 weeks, subject to usage, reducing the chances of you losing power in the time it takes to locate a dog should they leave your designated “Safe Zone.” Animo GPS is built to withstand the elements a dog can encounter, being fully waterproof and responsive in all weather conditions, yet still lightweight and securely attaches to a dog’s collar. To learn more about the benefits of Animo GPS, visit www.surepetcare.com/en-us/animo-gps.
About Merck Animal Health
At Merck, known as MSD outside of the United States Y Canada, we are united around our purpose: using the power of cutting-edge science to save and improve lives around the world. For more than a century, we have been at the forefront of research, developing innovative medicines, vaccines and health solutions for the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Rahway, NJ, USA, is Merck’s global animal health business. Through his commitment to the Health Science animals®, Merck Animal Health offers veterinarians, farmers, pet owners, and governments one of the broadest ranges of veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as a broad suite of connected technology including identification products, traceability and monitoring. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests heavily in dynamic and comprehensive R&D resources and modern global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, Twitter and Instagram.
Merck & Co., Inc. Forward Looking Statement, Rahway, NJUSA
This press release from Merck & Co., Inc., Rahway, NJ, USA (the “Company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the US Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and current expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or if risks or uncertainties materialize, actual results may differ materially from those set forth in forward-looking statements.
Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rates and currency exchange rate fluctuations; the impact of the global outbreak of the new coronavirus disease (COVID-19); the impact of the regulation of the pharmaceutical industry and health legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents obtained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; reliance on the effectiveness of the company’s patents and other protections for innovative products; and exposure to litigation, including patent litigation and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year then ended. December 31, 2021 and other company filings with the Securities and Exchange Commission (SEC) available on the SEC’s website (www.sec.gov).
- Sure Petcare 2021 survey of 9,841 US dog owners.
SOURCE Merck Animal Health